These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16461215)

  • 21. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
    Iloeje UH; Yang HI; Chen CJ
    Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The natural history of chronic HBV infection and geographical differences.
    Liaw YF; Brunetto MR; Hadziyannis S
    Antivir Ther; 2010; 15 Suppl 3():25-33. PubMed ID: 21041901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.
    Fattovich G; Bortolotti F; Donato F
    J Hepatol; 2008 Feb; 48(2):335-52. PubMed ID: 18096267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.
    Ahn JM; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    PLoS One; 2015; 10(12):e0144777. PubMed ID: 26696302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
    Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
    Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
    J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of viral hepatitis B.
    Pramoolsinsup C
    J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Natural history of chronic hepatitis B].
    Fonseca JC
    Rev Soc Bras Med Trop; 2007; 40(6):672-7. PubMed ID: 18200423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immune response induced by hepatitis B virus principal antigens.
    Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of chronic hepatitis B in children: an unresolved issue.
    Della Corte C; Nobili V; Comparcola D; Cainelli F; Vento S
    J Gastroenterol Hepatol; 2014 May; 29(5):912-9. PubMed ID: 24863185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia.
    Milosevic I; Delic D; Lazarevic I; Pavlovic IP; Korac M; Bojovic K; Jevtovic D
    J Clin Virol; 2013 Sep; 58(1):54-8. PubMed ID: 23838671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection.
    Tan Z; Li M; Kuang X; Tang Y; Fan Y; Deng G; Wang Y; He D
    J Clin Virol; 2014 Apr; 59(4):228-34. PubMed ID: 24529415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
    Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
    JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy.
    Ieluzzi D; Covolo L; Donato F; Fattovich G
    Dig Liver Dis; 2014 May; 46(5):427-32. PubMed ID: 24548819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B: Who and when to treat?
    Vlachogiannakos J; Papatheodoridis GV
    Liver Int; 2018 Feb; 38 Suppl 1():71-78. PubMed ID: 29427495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.
    Wu SY; Lan SH; Liu HS
    World J Gastroenterol; 2016 Jan; 22(1):176-87. PubMed ID: 26755869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of chronic hepatitis B: Evolution over two decades.
    Yuen MF; Lai CL
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The natural history of chronic hepatitis B virus infection.
    McMahon BJ
    Semin Liver Dis; 2004; 24 Suppl 1():17-21. PubMed ID: 15192797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.